Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Ensign Group (ENSG) On Buyout Spree To Enrich Portfolio

Published 06/05/2019, 10:22 PM
Updated 07/09/2023, 06:31 AM
ENSG
-
MOH
-
HCA
-
WCG
-

The Ensign Group, Inc. (NASDAQ:ENSG) recently announced that a unit of Cornerstone Healthcare, Inc., Ensign’s home health and hospice portfolio subsidiary, purchased the assets of Preceptor Health Care. The buyout was effective Jun 1, 2019.

With this deal, Cornerstone would be able to collaborate with Ensign Group’s skilled nursing and senior living facilities in Eastern Wisconsin. This transaction is also expected to allow the company to improve its health outcomes and reduce the re-hospitalization fees for patients.

Preceptor Health Care with its dedicated team offers unparalleled home health, hospice and therapy services in Eastern Wisconsin. It is thus, a perfect partner for a strategic relationship. This move in turn, has helped Ensign Group boost its capabilities.

The company also announced that it has purchased the real estate and operations of Golden Palms Rehabilitation and Retirement, effective Jun 1, 2019. This buyout complements its other five operations in South Texas. Notably, Golden Palms is the ideal choice for Ensign, well-equipped with outstanding physical facilities and trained professionals, who take good care of its residents.

These purchases have added to the company’s evolving portfolio and it now runs 198 skilled nursing facilities across 16 states. It also partly owns the real estate, regulating 77 of its 254 healthcare operations.

The company is also actively eyeing opportunities to buy strategic and underperforming home health, hospice and home care operations across the United States.

It boasts a strong inorganic growth story having closed several acquisitions in the past decade. Its historical improvement has been mainly driven by its proficiency in acquiring real estate or leasing post-acute care operations and transforming the same into market leaders. With each acquisition, the company honed its expertise, both clinically and financially. We expect all these buyouts to bode well for the company’s long-term growth.

Shares of this Zacks Rank #2 (Buy) company have surged 45.3% in the past year against its industry’s decline of 1.5%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



Other Stocks to Consider

Investors interested in the same space might also look into some other top-ranked stocks like HCA Healthcare, Inc. (NYSE:HCA) , Molina Healthcare, Inc (NYSE:MOH) and WellCare Health Plans, Inc. (NYSE:WCG) . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

HCA Healthcare provides health care services. In the last four quarters, the company delivered average beat of 15.74%. It carries a Zacks Rank of 2.

Molina Healthcare offers Medicaid-related solutions to meet the health care needs of low-income families and individuals. It sports a Zacks Rank #1 (Strong Buy). In the trailing four quarters, the company came up with average beat of 88.17%.

WellCare Health offers managed care services to government-sponsored health care programs. The company has a Zacks Rank of 2 and pulled off average positive surprise of 13.52% in the preceding four quarters.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>



Molina Healthcare, Inc (MOH): Free Stock Analysis Report

WellCare Health Plans, Inc. (WCG): Free Stock Analysis Report

HCA Healthcare, Inc. (HCA): Free Stock Analysis Report

The Ensign Group, Inc. (ENSG): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.